Kidswell Bio Corporation (4584.T)
JPY 131.0
(0.76%)
JPY 131.0
(0.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.33 Billion JPY | -142.43% |
| 2022 | -550.92 Million JPY | 15.39% |
| 2021 | -651.13 Million JPY | 32.85% |
| 2020 | -969.68 Million JPY | 16.55% |
| 2019 | -1.16 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -158.94 Million JPY | 76.23% |
| 2023 Q2 | -264.6 Million JPY | 41.85% |
| 2023 Q1 | -455.04 Million JPY | -9.54% |
| 2023 Q4 | -668.57 Million JPY | -1370.25% |
| 2023 Q3 | 52.63 Million JPY | 119.89% |
| 2023 FY | -1.33 Billion JPY | -142.43% |
| 2022 Q3 | -152.24 Million JPY | -409.87% |
| 2022 FY | -550.92 Million JPY | 15.39% |
| 2022 Q4 | -415.4 Million JPY | -172.86% |
| 2022 Q2 | 49.13 Million JPY | 0.0% |
| 2021 FY | -651.13 Million JPY | 32.85% |
| 2020 FY | -969.68 Million JPY | 16.55% |
| 2019 FY | -1.16 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 323.785% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -168.803% |
| GNI Group Ltd. | 13.1 Billion JPY | 110.189% |
| Linical Co., Ltd. | 725.72 Million JPY | 284.036% |
| Trans Genic Inc. | 89.43 Million JPY | 1593.355% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 6.336% |
| Soiken Holdings Inc. | -610 Million JPY | -118.948% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -72.839% |
| AnGes, Inc. | -11.96 Billion JPY | 88.84% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -19.165% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 85.979% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1380.546% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -54.509% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -19.572% |
| CanBas Co., Ltd. | -1.26 Billion JPY | -5.832% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -67.251% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -295.891% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -10.822% |
| PeptiDream Inc. | 6.77 Billion JPY | 119.719% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 30.798% |
| Ribomic Inc. | -1.11 Billion JPY | -19.656% |
| SanBio Company Limited | -4.53 Billion JPY | 70.575% |
| Healios K.K. | -3.37 Billion JPY | 60.474% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -15.628% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 4.156% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 4.804% |
| StemRIM | -2.07 Billion JPY | 35.665% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 209.341% |
| FunPep Company Limited | -994 Million JPY | -34.366% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -50.276% |
| Stella Pharma Corporation | -760.3 Million JPY | -75.667% |
| TMS Co., Ltd. | -943.25 Million JPY | -41.595% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -72.248% |
| Cuorips Inc. | -588.48 Million JPY | -126.954% |
| K Pharma,Inc. | 366.05 Million JPY | 464.86% |
| Takara Bio Inc. | 3 Billion JPY | 144.475% |
| ReproCELL Incorporated | -409.29 Million JPY | -226.318% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 12172.648% |
| StemCell Institute Inc. | 413.75 Million JPY | 422.796% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 1024.244% |
| CellSeed Inc. | -697.77 Million JPY | -91.408% |